These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21824055)

  • 1. Bringing greater transparency to "black box" warnings.
    Buckley NA; Rossi S
    Clin Toxicol (Phila); 2011 Jul; 49(6):448-51. PubMed ID: 21824055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A; Allan N; Wills B; Kang C; Leikin JB
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Yeh JS; Sarpatwari A; Kesselheim AS
    Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boxed warning inconsistencies between drug information resources and the prescribing information.
    Cheng CM; Fu C; Guglielmo BJ; Auerbach AD
    Am J Health Syst Pharm; 2011 Sep; 68(17):1626-31. PubMed ID: 21856808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in product information of biopharmaceuticals in the EU and the USA: implications for product development.
    Nieminen O; Kurki P; Nordström K
    Eur J Pharm Biopharm; 2005 Aug; 60(3):319-26. PubMed ID: 15996576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescriber compliance with black box warnings in older adult patients.
    Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
    Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.
    Kesselheim AS; Franklin JM; Avorn J; Duke JD
    BMJ Qual Saf; 2013 Sep; 22(9):727-34. PubMed ID: 23620531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.
    Schick A; Miller KL; Lanthier M; Dal Pan G; Nardinelli C
    Drug Saf; 2017 Jun; 40(6):497-503. PubMed ID: 28342075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of the Black Box Warning in Dermatology.
    Winterfield L; Vleugels RA; Park KK
    J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to black box warnings for prescription medications in outpatients.
    Lasser KE; Seger DL; Yu DT; Karson AS; Fiskio JM; Seger AC; Shah NR; Gandhi TK; Rothschild JM; Bates DW
    Arch Intern Med; 2006 Feb; 166(3):338-44. PubMed ID: 16476875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
    Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA drug prescribing warnings: is the black box half empty or half full?
    Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Black box warnings: what do they mean to pharmacists and patients.
    Martin CM; Borgelt L
    Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.
    Cook DM; Gurugubelli RK; Bero LA
    Drug Saf; 2009; 32(11):1057-66. PubMed ID: 19810777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.